Shareholders of Helios Technologies Inc (Symbol: HLIO) looking to boost their income beyond the stock's 0.5% annualized dividend yield can sell the September covered call at the $85 strike and collect the premium based on the $5.10 bid, which annualizes to an additional 12.4% ra
Shareholders of Helios Technologies Inc (Symbol: HLIO) looking to boost their income beyond the stock's 0.5% annualized dividend yield can sell the September covered call at the $85 strike and collect the premium based on the $5.10 bid, which annualizes to an additional 12.4% ra
Image source: The Motley Fool. Wednesday, February 25, 2026 at 10:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
Image source: The Motley Fool. Wednesday, February 25, 2026 at 10:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
Shareholders of Matson Inc (Symbol: MATX) looking to boost their income beyond the stock's 0.8% annualized dividend yield can sell the January 2028 covered call at the $220 strike and collect the premium based on the $21.50 bid, which annualizes to an additional 6.7% rate of ret
Shareholders of Matson Inc (Symbol: MATX) looking to boost their income beyond the stock's 0.8% annualized dividend yield can sell the January 2028 covered call at the $220 strike and collect the premium based on the $21.50 bid, which annualizes to an additional 6.7% rate of ret
In trading on Wednesday, shares of First Solar Inc (Symbol: FSLR) crossed below their 200 day moving average of $214.01, changing hands as low as $196.45 per share. First Solar Inc shares are currently trading off about 14.8% on the day. The chart below shows the one year perf
In trading on Wednesday, shares of First Solar Inc (Symbol: FSLR) crossed below their 200 day moving average of $214.01, changing hands as low as $196.45 per share. First Solar Inc shares are currently trading off about 14.8% on the day. The chart below shows the one year perf
Shareholders of Kinetik Holdings Inc (Symbol: KNTK) looking to boost their income beyond the stock's 7.5% annualized dividend yield can sell the March covered call at the $50 strike and collect the premium based on the 50 cents bid, which annualizes to an additional 18.4% rate o
Shareholders of Kinetik Holdings Inc (Symbol: KNTK) looking to boost their income beyond the stock's 7.5% annualized dividend yield can sell the March covered call at the $50 strike and collect the premium based on the 50 cents bid, which annualizes to an additional 18.4% rate o
Shareholders of Energizer Holdings Inc (Symbol: ENR) looking to boost their income beyond the stock's 5.6% annualized dividend yield can sell the August covered call at the $25 strike and collect the premium based on the $1.55 bid, which annualizes to an additional 14.9% rate of
Shareholders of Energizer Holdings Inc (Symbol: ENR) looking to boost their income beyond the stock's 5.6% annualized dividend yield can sell the August covered call at the $25 strike and collect the premium based on the $1.55 bid, which annualizes to an additional 14.9% rate of
Just when it seems like its stock can't possibly sink any more than it already has, GoDaddy (NYSE: GDDY) finds a way. As of 11:42 a.m. ET today, shares of the website-host and domain registrar are down another 15.9%, dragging them to a two-year low that's 65% below their early 2025 peak. Blame earnings... sort of. While its reported fiscal Q4 numbers topped analysts' estimates, revenue guidance fo...
Just when it seems like its stock can't possibly sink any more than it already has, GoDaddy (NYSE: GDDY) finds a way. As of 11:42 a.m. ET today, shares of the website-host and domain registrar are down another 15.9%, dragging them to a two-year low that's 65% below their early 2025 peak. Blame earnings... sort of. While its reported fiscal Q4 numbers topped analysts' estimates, revenue guidance for the quarter now underway was disappointing. In some ways, however, today's sizable stumble could also mark the stock's long-awaited bottom. Continue reading
narvo vexar/iStock via Getty Images The State of the Union address is playing as I write this. Which is timely, since I had already planned to write this article. And it has ZERO to do with politics. And everything to do with answering this question: How are the markets doing since the (second) inauguration of President Donald J. Trump on January 20, 2025? Just the facts. And then my evaluation of...
narvo vexar/iStock via Getty Images The State of the Union address is playing as I write this. Which is timely, since I had already planned to write this article. And it has ZERO to do with politics. And everything to do with answering this question: How are the markets doing since the (second) inauguration of President Donald J. Trump on January 20, 2025? Just the facts. And then my evaluation of what that means going forward. Let's dive in, starting with some macro background. I found an excellent commentary on the chart below in a social post by Gina Martin Adams of Bloomberg, who I interviewed on Seeking Alpha's Investing Experts podcast last year. It sets the stage for my account and forward-thinking view of what the return and risk picture looks like now. HB Wealth, Matthew Sanders In particular, she noted: S&P 500 Industrials’ forward P/E, at 26.5X, matches sector P/E in 2021, when earnings were impaired by the pandemic, and at 1.24X the index, is higher than at any point in the last 30 years. The only other times industrials’ relative P/E ratio spiked to near the current record were instances in which the Fed funds rate had dropped to 1% or lower. This time, the global defense spending boom, hyperscaler capex commitments, tax reform and easy monetary policy are sparking an extraordinary amount of stock market optimism in the outlook for an industrial profits acceleration in the years ahead. As a result, the group price-to-forward 3-year earnings multiple has topped 22X for the first time since 1999. The S&P 500's traditional version ( SPY ), the cap-weighted index, is in its customary position: ahead of the equal-weighted index ( RSP ). However, as we can see, the latter is catching up. Data by YCharts The returns have been sharp across most sectors. Technology ( XLK ) is the de facto leader in most up markets. But if there is any spotlight sector that provides some hope for the future extension of this rally, it is the one at the top. Industrials ( XLI ) ar...
Ayvens' 2025 Financial statements are available on Ayvens' corporate website (www.ayvens.com) in the Investors section under “Financial Results”. The financial information presented for the financial year ending 31 December 2025 was approved by the Board of Directors on 5 February 2026 under the chairmanship of Pierre Palmieri and has been prepared in accordance with IFRS as adopted in the Europea...
Ayvens' 2025 Financial statements are available on Ayvens' corporate website (www.ayvens.com) in the Investors section under “Financial Results”. The financial information presented for the financial year ending 31 December 2025 was approved by the Board of Directors on 5 February 2026 under the chairmanship of Pierre Palmieri and has been prepared in accordance with IFRS as adopted in the European Union and applicable at that date. The audit procedures carried out on the consolidated annual financial statements are in progress.
On Gold, Oil, & Uranium Billionaire natural resources investor Rick Rule , legendary short-seller Bill Fleckenstein , and veteran oil trader Erik Townsend join ZeroHedge this evening at 7PM ET to give their outlooks on three key commodities sectors: Gold, Oil, and Uranium. Gold and silver have, of course, exploded in price over the last 52 weeks with gold’s price almost doubling and reaching a hig...
On Gold, Oil, & Uranium Billionaire natural resources investor Rick Rule , legendary short-seller Bill Fleckenstein , and veteran oil trader Erik Townsend join ZeroHedge this evening at 7PM ET to give their outlooks on three key commodities sectors: Gold, Oil, and Uranium. Gold and silver have, of course, exploded in price over the last 52 weeks with gold’s price almost doubling and reaching a high of over $5500. Silver’s price more than tripled at one point and now sits ($87.50) just under 3X where it sat in February of last year ($32.93). Given the fast and intense rise, Rule recently reduced his silver position though remains long mining stocks. Time to Rotate into Oil? Oil on the other hand is down YoY, making it perhaps the most attractive commodity due to it being relatively cheap. Oil stocks are Rule’s number one investment position due to what he says is decades of massive underinvestment, a thesis he will expand upon this evening. Lastly, uranium mining stocks have seen a meteoric rise rivaling that of gold stock, broadly doubling with some names like Energy Fuels seeing an almost 400% increase YoY. Townsend will speak to the emerging technology in the nuclear energy space and Rule will speak to the long-term bull case and whether the mining stocks have flown too high too fast. We encourage commodity investors to tune in. Visit the ZeroHedge homepage at 7pm ET tonight to watch live and commercial-free. Or follow our Spotify and YouTube to watch after it airs. Tyler Durden Wed, 02/25/2026 - 11:45
UnitedHealth ( UNH ) declares $2.21/share quarterly dividend . Payable March 17; for shareholders of record March 9; ex-div March 9. See UNH Dividend Scorecard, Yield Chart, & Dividend Growth. More on UnitedHealth UnitedHealth: Compelling Value Proposition, But Risks Greatly Elevated UnitedHealth: 3 Reasons Not To Buy (Revisited) UnitedHealth: After The Collapse Medicare Advantage growth reportedl...
UnitedHealth ( UNH ) declares $2.21/share quarterly dividend . Payable March 17; for shareholders of record March 9; ex-div March 9. See UNH Dividend Scorecard, Yield Chart, & Dividend Growth. More on UnitedHealth UnitedHealth: Compelling Value Proposition, But Risks Greatly Elevated UnitedHealth: 3 Reasons Not To Buy (Revisited) UnitedHealth: After The Collapse Medicare Advantage growth reportedly slows down as UnitedHealth, CVS retreat Tiger Global takes new stakes in WLTH, trims NVDA, AMZN, and MSFT among Q4 moves
Monty Rakusen/Cultura via Getty Images Investment Thesis Steel Dynamics, Inc. ( STLD ) has had a decent year in 2025, with mixed financial results. Its stock price performance, in my view, more than fully reflects the financial results. The relative stock price outperformance may be the result of the overall market optimism stemming from the Trump administration's tariff program, meant to stimulat...
Monty Rakusen/Cultura via Getty Images Investment Thesis Steel Dynamics, Inc. ( STLD ) has had a decent year in 2025, with mixed financial results. Its stock price performance, in my view, more than fully reflects the financial results. The relative stock price outperformance may be the result of the overall market optimism stemming from the Trump administration's tariff program, meant to stimulate domestic industries. Steel Dynamics mostly operates in the US & Mexico, which arguably gives it an advantage relative to more international or foreign peers. The recent Supreme Court ruling puts most Trump tariff policies in doubt. It is too early to get a true sense of how it will all play out. For now, I have this stock as a hold, with either more clarity on the tariff issue needed or a significant pullback in its stock price, which would help to price in the resulting uncertainty, before I would consider initiating a position. Steel Dynamics Had A Decent Year Before I delve deeper into the likely effects of the Trump tariff, I want to briefly provide an overview of the company's business profile and its latest financial performance. Steel Dynamics is a major steel producer, offering a variety of products, ranging from steel as a bulk material to end-use products, such as beams used in construction or rail equipment. It also offers many non-ferrous products, such as recycled copper & aluminum. Its primary input is recycled metal. It has a capacity to produce 16 million tons of steel per year, which is equivalent to about a fifth of America's yearly steel output. Steel Dynamics share price & other metrics (Seeking Alpha) As the chart shows, it has had a decent half-decade in terms of its share price performance. In the past year , its share price rose even though earnings declined in 2025, according to its full-year report . Revenues came in at $18.2 billion for the full year of 2025, almost 4% higher than the previous year. Net income was down about 24% for the same per...
Minister ‘misspoke’ by telling MPs UK was ‘pausing for discussions with our American counterparts’, officials say UK politics live – latest updates Plans to hand over the Chagos Islands to Mauritius are still on track, the UK government has insisted, after a minister caused confusion by telling MPs that the deal was “paused”. Hamish Falconer, a Foreign Office minister and former diplomat, made the...
Minister ‘misspoke’ by telling MPs UK was ‘pausing for discussions with our American counterparts’, officials say UK politics live – latest updates Plans to hand over the Chagos Islands to Mauritius are still on track, the UK government has insisted, after a minister caused confusion by telling MPs that the deal was “paused”. Hamish Falconer, a Foreign Office minister and former diplomat, made the comment on Wednesday as the deal came under increasing pressure from opposition parties in the UK and from Donald Trump. Continue reading...
mohd izzuan Shares of Recursion Pharmaceuticals ( RXRX ) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials , thanks primarily to a milestone payment from partner Roche ( RHHBY ). For Q4, the Salt Lake City, Utah-based biotech reported $35.5M in total revenue, mainly comprising its collaboration revenue, compared to $4.5M in t...
mohd izzuan Shares of Recursion Pharmaceuticals ( RXRX ) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials , thanks primarily to a milestone payment from partner Roche ( RHHBY ). For Q4, the Salt Lake City, Utah-based biotech reported $35.5M in total revenue, mainly comprising its collaboration revenue, compared to $4.5M in the prior year period, exceeding the consensus by nearly $11M. The company attributed the revenue increase primarily to a portion of a $30M milestone payment received from Roche ( RHHBF ) in October. For the full year, its total revenue climbed ~27% YoY to $74.7M due to the addition of financials from its Exscientia acquisition in 2024. Meanwhile, the company's net loss per share reached $0.21, exceeding the consensus by $0.08, as its R&D expenses and SG&A expenses fell ~2% YoY and ~56% YoY to $95.9M and $33.7M, respectively. In terms of liquidity, Recursion ( RXRX ) reported $743.3M of cash and cash equivalents as of Dec. 31 compared to $594.4M a year ago and projected its cash runway to extend into 2028 without additional financing. More on Recursion Pharmaceuticals Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference Transcript Recursion Pharmaceuticals: Stock Unresponsive To Clinical Updates Recursion Pharmaceuticals, Inc. (RXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Recursion Pharmaceuticals GAAP EPS of -$0.21 beats by $0.08, revenue of $35.54M beats by $10.98M Recursion Pharmaceuticals Q4 2025 Earnings Preview